nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—SLC6A2—Cyproheptadine—allergic rhinitis	0.391	1	CbGbCtD
Droxidopa—Urinary tract infection—Desloratadine—allergic rhinitis	0.014	0.028	CcSEcCtD
Droxidopa—Urinary tract infection—Olopatadine—allergic rhinitis	0.012	0.024	CcSEcCtD
Droxidopa—Syncope—Cyproheptadine—allergic rhinitis	0.0104	0.0208	CcSEcCtD
Droxidopa—Loss of consciousness—Cyproheptadine—allergic rhinitis	0.0102	0.0204	CcSEcCtD
Droxidopa—Confusional state—Cyproheptadine—allergic rhinitis	0.00953	0.0191	CcSEcCtD
Droxidopa—Shock—Cyproheptadine—allergic rhinitis	0.0093	0.0186	CcSEcCtD
Droxidopa—Urinary tract infection—Cetirizine—allergic rhinitis	0.00849	0.017	CcSEcCtD
Droxidopa—Urinary tract infection—Flunisolide—allergic rhinitis	0.00835	0.0167	CcSEcCtD
Droxidopa—Feeling abnormal—Cyproheptadine—allergic rhinitis	0.00779	0.0156	CcSEcCtD
Droxidopa—Confusional state—Diphenhydramine—allergic rhinitis	0.00775	0.0155	CcSEcCtD
Droxidopa—Confusional state—Dimenhydrinate—allergic rhinitis	0.00775	0.0155	CcSEcCtD
Droxidopa—Arrhythmia—Loratadine—allergic rhinitis	0.00744	0.0149	CcSEcCtD
Droxidopa—Arrhythmia—Cetirizine—allergic rhinitis	0.007	0.014	CcSEcCtD
Droxidopa—Syncope—Loratadine—allergic rhinitis	0.0065	0.013	CcSEcCtD
Droxidopa—Feeling abnormal—Olopatadine—allergic rhinitis	0.00647	0.013	CcSEcCtD
Droxidopa—Loss of consciousness—Loratadine—allergic rhinitis	0.00637	0.0128	CcSEcCtD
Droxidopa—Feeling abnormal—Diphenhydramine—allergic rhinitis	0.00633	0.0127	CcSEcCtD
Droxidopa—Feeling abnormal—Dimenhydrinate—allergic rhinitis	0.00633	0.0127	CcSEcCtD
Droxidopa—Hypertension—Loratadine—allergic rhinitis	0.00626	0.0125	CcSEcCtD
Droxidopa—Dizziness—Cyproheptadine—allergic rhinitis	0.00625	0.0125	CcSEcCtD
Droxidopa—Syncope—Cetirizine—allergic rhinitis	0.00612	0.0122	CcSEcCtD
Droxidopa—Dizziness—Desloratadine—allergic rhinitis	0.00607	0.0122	CcSEcCtD
Droxidopa—Syncope—Flunisolide—allergic rhinitis	0.00602	0.012	CcSEcCtD
Droxidopa—Loss of consciousness—Cetirizine—allergic rhinitis	0.006	0.012	CcSEcCtD
Droxidopa—Headache—Cyproheptadine—allergic rhinitis	0.00592	0.0118	CcSEcCtD
Droxidopa—Loss of consciousness—Flunisolide—allergic rhinitis	0.0059	0.0118	CcSEcCtD
Droxidopa—Hypertension—Cetirizine—allergic rhinitis	0.00589	0.0118	CcSEcCtD
Droxidopa—Shock—Loratadine—allergic rhinitis	0.00582	0.0117	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisolone—allergic rhinitis	0.00579	0.0116	CcSEcCtD
Droxidopa—Hypertension—Flunisolide—allergic rhinitis	0.00579	0.0116	CcSEcCtD
Droxidopa—Headache—Desloratadine—allergic rhinitis	0.00575	0.0115	CcSEcCtD
Droxidopa—Cardiac failure congestive—Hydrocortisone—allergic rhinitis	0.00566	0.0113	CcSEcCtD
Droxidopa—Confusional state—Cetirizine—allergic rhinitis	0.00562	0.0112	CcSEcCtD
Droxidopa—Nausea—Cyproheptadine—allergic rhinitis	0.00561	0.0112	CcSEcCtD
Droxidopa—Shock—Cetirizine—allergic rhinitis	0.00548	0.011	CcSEcCtD
Droxidopa—Nausea—Desloratadine—allergic rhinitis	0.00546	0.0109	CcSEcCtD
Droxidopa—Shock—Flunisolide—allergic rhinitis	0.00539	0.0108	CcSEcCtD
Droxidopa—Cardiac failure congestive—Triamcinolone—allergic rhinitis	0.00533	0.0107	CcSEcCtD
Droxidopa—Cardiac failure congestive—Methylprednisolone—allergic rhinitis	0.00532	0.0106	CcSEcCtD
Droxidopa—Dizziness—Olopatadine—allergic rhinitis	0.00519	0.0104	CcSEcCtD
Droxidopa—Dizziness—Dimenhydrinate—allergic rhinitis	0.00508	0.0102	CcSEcCtD
Droxidopa—Dizziness—Diphenhydramine—allergic rhinitis	0.00508	0.0102	CcSEcCtD
Droxidopa—Headache—Olopatadine—allergic rhinitis	0.00492	0.00985	CcSEcCtD
Droxidopa—Feeling abnormal—Loratadine—allergic rhinitis	0.00488	0.00976	CcSEcCtD
Droxidopa—Cardiac failure congestive—Betamethasone—allergic rhinitis	0.00483	0.00968	CcSEcCtD
Droxidopa—Cardiac failure congestive—Dexamethasone—allergic rhinitis	0.00483	0.00968	CcSEcCtD
Droxidopa—Headache—Diphenhydramine—allergic rhinitis	0.00481	0.00964	CcSEcCtD
Droxidopa—Headache—Dimenhydrinate—allergic rhinitis	0.00481	0.00964	CcSEcCtD
Droxidopa—Nausea—Olopatadine—allergic rhinitis	0.00466	0.00934	CcSEcCtD
Droxidopa—Feeling abnormal—Cetirizine—allergic rhinitis	0.00459	0.00919	CcSEcCtD
Droxidopa—Nausea—Dimenhydrinate—allergic rhinitis	0.00456	0.00914	CcSEcCtD
Droxidopa—Nausea—Diphenhydramine—allergic rhinitis	0.00456	0.00914	CcSEcCtD
Droxidopa—Feeling abnormal—Flunisolide—allergic rhinitis	0.00451	0.00903	CcSEcCtD
Droxidopa—Dizziness—Loratadine—allergic rhinitis	0.00391	0.00783	CcSEcCtD
Droxidopa—Headache—Loratadine—allergic rhinitis	0.00371	0.00742	CcSEcCtD
Droxidopa—Dizziness—Cetirizine—allergic rhinitis	0.00368	0.00737	CcSEcCtD
Droxidopa—Dizziness—Flunisolide—allergic rhinitis	0.00362	0.00725	CcSEcCtD
Droxidopa—Nausea—Loratadine—allergic rhinitis	0.00352	0.00704	CcSEcCtD
Droxidopa—Headache—Cetirizine—allergic rhinitis	0.00349	0.00698	CcSEcCtD
Droxidopa—Headache—Flunisolide—allergic rhinitis	0.00343	0.00687	CcSEcCtD
Droxidopa—Nausea—Cetirizine—allergic rhinitis	0.00331	0.00662	CcSEcCtD
Droxidopa—Nausea—Flunisolide—allergic rhinitis	0.00325	0.00651	CcSEcCtD
Droxidopa—Arrhythmia—Prednisolone—allergic rhinitis	0.00325	0.0065	CcSEcCtD
Droxidopa—Arrhythmia—Hydrocortisone—allergic rhinitis	0.00317	0.00635	CcSEcCtD
Droxidopa—Dizziness—Montelukast—allergic rhinitis	0.00309	0.00618	CcSEcCtD
Droxidopa—Arrhythmia—Triamcinolone—allergic rhinitis	0.00299	0.00598	CcSEcCtD
Droxidopa—Arrhythmia—Methylprednisolone—allergic rhinitis	0.00298	0.00596	CcSEcCtD
Droxidopa—Headache—Montelukast—allergic rhinitis	0.00293	0.00586	CcSEcCtD
Droxidopa—Syncope—Prednisolone—allergic rhinitis	0.00284	0.00568	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisolone—allergic rhinitis	0.00278	0.00557	CcSEcCtD
Droxidopa—Nausea—Montelukast—allergic rhinitis	0.00277	0.00555	CcSEcCtD
Droxidopa—Syncope—Hydrocortisone—allergic rhinitis	0.00277	0.00555	CcSEcCtD
Droxidopa—Hypertension—Prednisolone—allergic rhinitis	0.00273	0.00547	CcSEcCtD
Droxidopa—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.00272	0.00544	CcSEcCtD
Droxidopa—Arrhythmia—Dexamethasone—allergic rhinitis	0.00271	0.00542	CcSEcCtD
Droxidopa—Arrhythmia—Betamethasone—allergic rhinitis	0.00271	0.00542	CcSEcCtD
Droxidopa—Hypertension—Hydrocortisone—allergic rhinitis	0.00267	0.00534	CcSEcCtD
Droxidopa—Syncope—Triamcinolone—allergic rhinitis	0.00261	0.00522	CcSEcCtD
Droxidopa—Syncope—Methylprednisolone—allergic rhinitis	0.0026	0.00521	CcSEcCtD
Droxidopa—Loss of consciousness—Triamcinolone—allergic rhinitis	0.00256	0.00512	CcSEcCtD
Droxidopa—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.00255	0.00511	CcSEcCtD
Droxidopa—Shock—Prednisolone—allergic rhinitis	0.00254	0.00508	CcSEcCtD
Droxidopa—Hypertension—Triamcinolone—allergic rhinitis	0.00251	0.00503	CcSEcCtD
Droxidopa—Hypertension—Methylprednisolone—allergic rhinitis	0.00251	0.00502	CcSEcCtD
Droxidopa—Shock—Hydrocortisone—allergic rhinitis	0.00248	0.00497	CcSEcCtD
Droxidopa—Confusional state—Methylprednisolone—allergic rhinitis	0.00239	0.00478	CcSEcCtD
Droxidopa—Syncope—Dexamethasone—allergic rhinitis	0.00237	0.00474	CcSEcCtD
Droxidopa—Syncope—Betamethasone—allergic rhinitis	0.00237	0.00474	CcSEcCtD
Droxidopa—Shock—Triamcinolone—allergic rhinitis	0.00234	0.00468	CcSEcCtD
Droxidopa—Shock—Methylprednisolone—allergic rhinitis	0.00233	0.00467	CcSEcCtD
Droxidopa—Loss of consciousness—Betamethasone—allergic rhinitis	0.00232	0.00464	CcSEcCtD
Droxidopa—Loss of consciousness—Dexamethasone—allergic rhinitis	0.00232	0.00464	CcSEcCtD
Droxidopa—Hypertension—Dexamethasone—allergic rhinitis	0.00228	0.00456	CcSEcCtD
Droxidopa—Hypertension—Betamethasone—allergic rhinitis	0.00228	0.00456	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisolone—allergic rhinitis	0.00213	0.00426	CcSEcCtD
Droxidopa—Shock—Betamethasone—allergic rhinitis	0.00212	0.00424	CcSEcCtD
Droxidopa—Shock—Dexamethasone—allergic rhinitis	0.00212	0.00424	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrocortisone—allergic rhinitis	0.00208	0.00416	CcSEcCtD
Droxidopa—Feeling abnormal—Triamcinolone—allergic rhinitis	0.00196	0.00392	CcSEcCtD
Droxidopa—Feeling abnormal—Methylprednisolone—allergic rhinitis	0.00195	0.00391	CcSEcCtD
Droxidopa—Feeling abnormal—Betamethasone—allergic rhinitis	0.00178	0.00355	CcSEcCtD
Droxidopa—Feeling abnormal—Dexamethasone—allergic rhinitis	0.00178	0.00355	CcSEcCtD
Droxidopa—Dizziness—Prednisolone—allergic rhinitis	0.00171	0.00342	CcSEcCtD
Droxidopa—Dizziness—Hydrocortisone—allergic rhinitis	0.00167	0.00334	CcSEcCtD
Droxidopa—Headache—Prednisolone—allergic rhinitis	0.00162	0.00324	CcSEcCtD
Droxidopa—Headache—Hydrocortisone—allergic rhinitis	0.00158	0.00316	CcSEcCtD
Droxidopa—Dizziness—Triamcinolone—allergic rhinitis	0.00157	0.00314	CcSEcCtD
Droxidopa—Dizziness—Methylprednisolone—allergic rhinitis	0.00157	0.00314	CcSEcCtD
Droxidopa—Nausea—Prednisolone—allergic rhinitis	0.00153	0.00307	CcSEcCtD
Droxidopa—Nausea—Hydrocortisone—allergic rhinitis	0.0015	0.003	CcSEcCtD
Droxidopa—Headache—Triamcinolone—allergic rhinitis	0.00149	0.00298	CcSEcCtD
Droxidopa—Headache—Methylprednisolone—allergic rhinitis	0.00148	0.00297	CcSEcCtD
Droxidopa—Dizziness—Betamethasone—allergic rhinitis	0.00142	0.00285	CcSEcCtD
Droxidopa—Dizziness—Dexamethasone—allergic rhinitis	0.00142	0.00285	CcSEcCtD
Droxidopa—Nausea—Triamcinolone—allergic rhinitis	0.00141	0.00282	CcSEcCtD
Droxidopa—Nausea—Methylprednisolone—allergic rhinitis	0.00141	0.00282	CcSEcCtD
Droxidopa—Headache—Betamethasone—allergic rhinitis	0.00135	0.0027	CcSEcCtD
Droxidopa—Headache—Dexamethasone—allergic rhinitis	0.00135	0.0027	CcSEcCtD
Droxidopa—Nausea—Dexamethasone—allergic rhinitis	0.00128	0.00256	CcSEcCtD
Droxidopa—Nausea—Betamethasone—allergic rhinitis	0.00128	0.00256	CcSEcCtD
Droxidopa—ADRA2A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000714	0.00651	CbGpPWpGaD
Droxidopa—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000714	0.0065	CbGpPWpGaD
Droxidopa—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000701	0.00638	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000699	0.00637	CbGpPWpGaD
Droxidopa—ADRB1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000692	0.0063	CbGpPWpGaD
Droxidopa—ADRA1D—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00069	0.00628	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000688	0.00627	CbGpPWpGaD
Droxidopa—ADRA2B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000686	0.00624	CbGpPWpGaD
Droxidopa—ADRB2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000677	0.00616	CbGpPWpGaD
Droxidopa—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000663	0.00604	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000651	0.00593	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000648	0.0059	CbGpPWpGaD
Droxidopa—ADRA2C—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000641	0.00583	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000632	0.00575	CbGpPWpGaD
Droxidopa—ADRA1B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00063	0.00574	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000628	0.00572	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000617	0.00562	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000611	0.00557	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000593	0.0054	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000588	0.00535	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00058	0.00528	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000575	0.00524	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000573	0.00521	CbGpPWpGaD
Droxidopa—ADRA1B—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000572	0.00521	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00057	0.00519	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000568	0.00517	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000567	0.00517	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000563	0.00513	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00056	0.0051	CbGpPWpGaD
Droxidopa—ADRA1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00056	0.0051	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000549	0.005	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000548	0.00499	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00054	0.00492	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—TAC1—allergic rhinitis	0.000534	0.00486	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000533	0.00485	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00053	0.00483	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000524	0.00477	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000522	0.00475	CbGpPWpGaD
Droxidopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00052	0.00474	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000515	0.00469	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000512	0.00466	CbGpPWpGaD
Droxidopa—ADRA1A—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000508	0.00463	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000506	0.00461	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000498	0.00453	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000496	0.00451	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00048	0.00437	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CCL11—allergic rhinitis	0.000479	0.00436	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000473	0.00431	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000466	0.00424	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000463	0.00422	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000457	0.00416	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000455	0.00414	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000452	0.00411	CbGpPWpGaD
Droxidopa—ADRA1B—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000449	0.00409	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000447	0.00407	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000446	0.00406	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000442	0.00402	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CCL11—allergic rhinitis	0.000436	0.00397	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000433	0.00394	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CCL11—allergic rhinitis	0.000432	0.00393	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000431	0.00392	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00043	0.00391	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CCL11—allergic rhinitis	0.000427	0.00388	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000418	0.00381	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000416	0.00379	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000412	0.00375	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000411	0.00374	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000407	0.00371	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CCL11—allergic rhinitis	0.000404	0.00367	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CCL11—allergic rhinitis	0.000397	0.00362	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00039	0.00355	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000385	0.00351	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000384	0.0035	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000379	0.00345	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CCL11—allergic rhinitis	0.000377	0.00343	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000365	0.00333	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000357	0.00325	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CCL11—allergic rhinitis	0.000353	0.00321	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—TAC1—allergic rhinitis	0.000348	0.00317	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000339	0.00309	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000337	0.00307	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	0.000328	0.00298	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000325	0.00296	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000324	0.00295	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000322	0.00293	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000318	0.0029	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—TAC1—allergic rhinitis	0.000317	0.00288	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—TAC1—allergic rhinitis	0.000314	0.00286	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000313	0.00285	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—TAC1—allergic rhinitis	0.00031	0.00282	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—TAC1—allergic rhinitis	0.000302	0.00275	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000301	0.00274	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000296	0.0027	CbGpPWpGaD
Droxidopa—PAH—Disease—SMAD3—allergic rhinitis	0.000296	0.00269	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000295	0.00269	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PTGDR2—allergic rhinitis	0.000294	0.00268	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—TAC1—allergic rhinitis	0.000293	0.00267	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000293	0.00266	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000289	0.00263	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—TAC1—allergic rhinitis	0.000289	0.00263	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—IL5—allergic rhinitis	0.00028	0.00255	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00028	0.00255	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—TAC1—allergic rhinitis	0.000274	0.00249	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000273	0.00249	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000269	0.00245	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000263	0.0024	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IL5—allergic rhinitis	0.000261	0.00238	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—TAC1—allergic rhinitis	0.000256	0.00233	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000255	0.00232	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL5—allergic rhinitis	0.000255	0.00232	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000254	0.00232	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000253	0.0023	CbGpPWpGaD
Droxidopa—SLC6A2—NRF2 pathway—TGFB1—allergic rhinitis	0.00025	0.00228	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00025	0.00227	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCL11—allergic rhinitis	0.000246	0.00224	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000244	0.00223	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IL5—allergic rhinitis	0.000244	0.00222	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000239	0.00218	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	0.000238	0.00217	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000236	0.00215	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000232	0.00212	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000232	0.00211	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000231	0.0021	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00023	0.00209	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000227	0.00206	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCL11—allergic rhinitis	0.000224	0.00204	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCL11—allergic rhinitis	0.000223	0.00203	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000222	0.00202	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCL11—allergic rhinitis	0.000222	0.00202	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCL11—allergic rhinitis	0.000219	0.00199	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000214	0.00195	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000211	0.00192	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCL11—allergic rhinitis	0.000207	0.00189	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000206	0.00188	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCL11—allergic rhinitis	0.000204	0.00186	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL5—allergic rhinitis	0.000198	0.0018	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—TAC1—allergic rhinitis	0.000197	0.00179	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000192	0.00175	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTGDR2—allergic rhinitis	0.000191	0.00174	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000187	0.00171	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL5—allergic rhinitis	0.000183	0.00166	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCL11—allergic rhinitis	0.000181	0.00165	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—TAC1—allergic rhinitis	0.000179	0.00163	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TAC1—allergic rhinitis	0.000178	0.00162	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—TAC1—allergic rhinitis	0.000177	0.00162	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—TAC1—allergic rhinitis	0.000175	0.00159	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000174	0.00159	CbGpPWpGaD
Droxidopa—PAH—Disease—CD4—allergic rhinitis	0.000174	0.00159	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000174	0.00159	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTGDR2—allergic rhinitis	0.000173	0.00157	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTGDR2—allergic rhinitis	0.000171	0.00155	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	0.000168	0.00153	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL5—allergic rhinitis	0.000166	0.00152	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL5—allergic rhinitis	0.000166	0.00151	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—TAC1—allergic rhinitis	0.000166	0.00151	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL5—allergic rhinitis	0.000165	0.0015	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—TAC1—allergic rhinitis	0.000163	0.00149	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL5—allergic rhinitis	0.000163	0.00148	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TAC1—allergic rhinitis	0.000163	0.00148	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TAC1—allergic rhinitis	0.000162	0.00147	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTGDR2—allergic rhinitis	0.000161	0.00147	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TAC1—allergic rhinitis	0.000161	0.00147	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TAC1—allergic rhinitis	0.000159	0.00145	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTGDR2—allergic rhinitis	0.000159	0.00145	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL5—allergic rhinitis	0.000154	0.0014	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL5—allergic rhinitis	0.000152	0.00138	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL5—allergic rhinitis	0.000151	0.00138	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000151	0.00137	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TAC1—allergic rhinitis	0.00015	0.00137	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL5—allergic rhinitis	0.00015	0.00137	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00015	0.00137	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL5—allergic rhinitis	0.00015	0.00136	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TAC1—allergic rhinitis	0.000148	0.00135	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL5—allergic rhinitis	0.000148	0.00135	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL11—allergic rhinitis	0.000145	0.00132	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—TAC1—allergic rhinitis	0.000145	0.00132	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTGDR2—allergic rhinitis	0.000141	0.00129	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000141	0.00128	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL5—allergic rhinitis	0.00014	0.00127	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL5—allergic rhinitis	0.000138	0.00125	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000137	0.00125	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000136	0.00123	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL5—allergic rhinitis	0.000135	0.00123	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	0.000135	0.00123	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000134	0.00122	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL11—allergic rhinitis	0.000132	0.0012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TAC1—allergic rhinitis	0.000132	0.0012	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	0.000131	0.00119	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL11—allergic rhinitis	0.000131	0.00119	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL11—allergic rhinitis	0.000129	0.00118	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000127	0.00115	CbGpPWpGaD
Droxidopa—PAH—Disease—TGFB1—allergic rhinitis	0.000125	0.00114	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	0.000125	0.00114	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000125	0.00114	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL11—allergic rhinitis	0.000122	0.00111	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL5—allergic rhinitis	0.000122	0.00111	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	0.000122	0.00111	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL11—allergic rhinitis	0.00012	0.0011	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000114	0.00104	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	0.000114	0.00103	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000111	0.00101	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL11—allergic rhinitis	0.000107	0.000974	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SMAD3—allergic rhinitis	0.000106	0.000964	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TAC1—allergic rhinitis	0.000105	0.00096	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000103	0.000937	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	9.94e-05	0.000905	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL5—allergic rhinitis	9.8e-05	0.000892	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TAC1—allergic rhinitis	9.61e-05	0.000875	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TAC1—allergic rhinitis	9.52e-05	0.000867	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TAC1—allergic rhinitis	9.4e-05	0.000856	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL5—allergic rhinitis	8.93e-05	0.000813	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TAC1—allergic rhinitis	8.89e-05	0.000809	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL5—allergic rhinitis	8.85e-05	0.000806	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TAC1—allergic rhinitis	8.75e-05	0.000797	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL5—allergic rhinitis	8.74e-05	0.000795	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL5—allergic rhinitis	8.27e-05	0.000753	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL5—allergic rhinitis	8.13e-05	0.000741	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—allergic rhinitis	7.78e-05	0.000708	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TAC1—allergic rhinitis	7.77e-05	0.000708	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—allergic rhinitis	7.27e-05	0.000662	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL5—allergic rhinitis	7.23e-05	0.000658	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	7.22e-05	0.000657	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SMAD3—allergic rhinitis	6.9e-05	0.000628	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	6.71e-05	0.000611	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SMAD3—allergic rhinitis	6.29e-05	0.000572	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SMAD3—allergic rhinitis	6.23e-05	0.000567	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SMAD3—allergic rhinitis	6.15e-05	0.00056	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	5.9e-05	0.000537	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SMAD3—allergic rhinitis	5.82e-05	0.00053	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SMAD3—allergic rhinitis	5.73e-05	0.000521	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NFKB1—allergic rhinitis	5.38e-05	0.00049	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SMAD3—allergic rhinitis	5.09e-05	0.000463	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	4.72e-05	0.00043	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—allergic rhinitis	4.48e-05	0.000408	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NFKB1—allergic rhinitis	3.51e-05	0.000319	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NFKB1—allergic rhinitis	3.19e-05	0.000291	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NFKB1—allergic rhinitis	3.17e-05	0.000288	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NFKB1—allergic rhinitis	3.13e-05	0.000285	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NFKB1—allergic rhinitis	2.96e-05	0.000269	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—allergic rhinitis	2.92e-05	0.000266	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFKB1—allergic rhinitis	2.91e-05	0.000265	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—allergic rhinitis	2.66e-05	0.000242	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—allergic rhinitis	2.64e-05	0.00024	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—allergic rhinitis	2.6e-05	0.000237	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFKB1—allergic rhinitis	2.58e-05	0.000235	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—allergic rhinitis	2.46e-05	0.000224	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—allergic rhinitis	2.42e-05	0.000221	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	2.4e-05	0.000219	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—allergic rhinitis	2.15e-05	0.000196	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	2e-05	0.000182	CbGpPWpGaD
